在整个转录组中解读异常拼接在黑色素瘤MAPK向耐药性演变中的作用
Jing Yu1, Xiujing He1, Xueyan Wang1
1Institute of Breast Health Medicine, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University and Collaborative Innovation Center, 610041, Chengdu, Sichuan, China.
EMBO reports
|July 18, 2025
概括
黑色素瘤的耐药性涉及基因拼接的变化. 一个特定的AKT2基因开关通过激活S6激酶来驱动对BRAF抑制剂的耐药性,从而提供新的治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 药物耐药性限制了黑色素瘤中MAPK向治疗的疗效.
- 耐药性的机制在遗传,表观遗传和转录层面是已知的.
- 在黑色素瘤药物耐药性中,转录后拼接调节的理解很少.
研究的目的:
- 为了研究在获得的治疗耐药性期间黑色素瘤的替代拼接变化.
- 为了确定特定的拼接事件及其在BRAF抑制剂耐药性的功能后果.
- 探索拼接因子在介导阻力机制中的作用.
主要方法:
- 分析患者匹配的治疗前和耐药黑色素瘤活检.
- 使用分子技术识别和验证替代拼接事件.
- 在黑色素瘤细胞系中进行功能性研究,以评估剪接变化的对药物耐药性的影响.
主要成果:
- 在黑色素瘤治疗耐药性期间观察到广泛的替代拼接变化.
- 拼接扰乱在MAPK和PI3K-AKT通路基因中最为突出.
- 在耐药活检中发现了从AKT2异型210到206的切换,导致通过S6激酶激活导致激酶过活和BRAF抑制剂耐药性.
- 拼接因子hnRNPK参与驱动AKT2拼接开关.
结论:
- 替代拼接在黑色素瘤耐药性方面发挥着重要作用.
- AKT2拼接开关是赋予对BRAF抑制剂耐药性的关键机制.
- 替代拼接异型代表了黑色素瘤临床诊断和治疗的潜在目标.
相关概念视频
RNA Splicing
57.1K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
57.1K
MAPK Signaling Cascades
6.1K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.1K
Interactions Between Signaling Pathways
6.5K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.5K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K


